1–3 of 3 results for intravitreal injection pain
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 inReducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
Karen M Wai, MD
Annual Meeting Talks
2025
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
STEPHEN J SMITH, MD
Updates from the Field
Comparing Post Intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-Hour Period: Randomized Placebo-Controlled Trial
On Demand Cases, Courses, and Papers
2022